Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by pericles1on Sep 29, 2010 10:50am
528 Views
Post# 17506261

RE: “MONSTER” is shaping up!

RE: “MONSTER” is shaping up!

Hey I'm beginning to understand yours posts, amazing!

Thought the latest conference call was fine, not much new except Brad does seem to be holding off on financing for another month or two which shows confidence I suppose.  Did say they  notice the treatment in lung cancer really reduces the bleeding in the lungs which I suppose he is saying tjhat  is a increase in quality of life if not the length of life, that was nice to hear!

In the interest of honesty I have decided to trade about 10% of my shares here in the 4.90 US area. I'll see how I make out if I can't buy them back cheaper I'll still be a very happy camper. Never did this before but still think when financing comes the stock will take a hit.  Trial news may prevent that we shall see.

The Patent was very nice but I think unless one is an expert on patent law it's really difficult to know how valuable it will be in future. I have no doubt if it holds up in court it will be very valuable but that living organism thing does bother me a little. That's years off anyway, now all we need is to get the trial approved!
Bullboard Posts